About Dawatek
Dawatek is a company based in Oak Park (United States) founded in 2017 by Davina Moossazadeh and Isaac Chadri. Dawatek has raised $100 thousand across 1 funding round from investors including Gener8tor. Dawatek operates in a competitive market with competitors including Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others.
- Headquarter Oak Park, United States
- Founders Davina Moossazadeh, Isaac Chadri
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100 K (USD)
in 1 rounds
-
Latest Funding Round
$100 K (USD), Seed
Sep 22, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Dawatek
Unlock access to complete
Unlock access to complete
Funding Insights of Dawatek
Dawatek has successfully raised a total of $100K through 1 strategic funding round. The most recent funding activity was a Seed round of $100 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dawatek
Dawatek has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gener8tor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated via a 12-week program with funding support.
|
Locked | Locked | Locked |
Investor details for Dawatek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dawatek
Investment portfolio details for Dawatek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dawatek
Detailed financials for Dawatek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dawatek Comparisons
Peer comparison for Dawatek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dawatek
Dawatek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Fluxion Biosciences, Ionpath, SamanTree Medical and Phase Focus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
|
| Locked | Locked | Locked |
Multiplexed ion beam imaging platform for tissue biopsies is developed.
|
|
| Locked | Locked | Locked |
A surgical digital microscope for tumor resection is developed.
|
|
| Locked | Locked | Locked |
Provider of virtual lens that generates High definition images without high-quality lenses
|
|
| Locked | Locked | Locked |
Solutions for image-guided interventional procedures are developed.
|
Detailed competitors of Dawatek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dawatek
Complete news archive for Dawatek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dawatek
Dawatek was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Dawatek is headquartered in Oak Park, United States. It is registered at Oak Park, Illinois, United States.
Isaac Chadri is the current CEO of Dawatek. They have also founded this company.
Dawatek is a funded company, having raised a total of $100K across 1 funding round to date.
Dawatek was founded in 2017 in Oak Park, United States, as a developer of medical imaging devices focused on infectious and chronic diseases. Devices such as RTK-19 are utilized for detecting bacterial, viral conditions, cancer, and COVID-19, while RIM-25 is employed for scanning the human body to identify oral cancer. Operations center on healthcare technology innovation within the medical diagnostics sector.
Dawatek's top competitors include Scholar Rock, Ionpath and Aillis.
Dawatek has 1 investor. Key investors include Gener8tor.